314 related articles for article (PubMed ID: 33016289)
1. Cascade reaction-mediated efficient ferroptosis synergizes with immunomodulation for high-performance cancer therapy.
Li Z; Rong L
Biomater Sci; 2020 Nov; 8(22):6272-6285. PubMed ID: 33016289
[TBL] [Abstract][Full Text] [Related]
2. Engineering Magnetosomes for Ferroptosis/Immunomodulation Synergism in Cancer.
Zhang F; Li F; Lu GH; Nie W; Zhang L; Lv Y; Bao W; Gao X; Wei W; Pu K; Xie HY
ACS Nano; 2019 May; 13(5):5662-5673. PubMed ID: 31046234
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitor-enhanced nanocatalytic ferroptosis induction for stimuli-responsive dual-modal molecular imaging guided cancer radiosensitization.
Zheng S; Hu H; Hou M; Zhu K; Wu Z; Qi L; Xia H; Liu G; Ren Y; Xu Y; Yan C; Zhao B
Acta Biomater; 2023 May; 162():72-84. PubMed ID: 36931419
[TBL] [Abstract][Full Text] [Related]
4. A Strategy of Fenton Reaction Cycloacceleration for High-Performance Ferroptosis Therapy Initiated by Tumor Microenvironment Remodeling.
Huang L; Feng J; Zhu J; Yang J; Xiong W; Lu X; Chen S; Yang S; Li Y; Xu Y; Shen Z
Adv Healthc Mater; 2023 Jul; 12(18):e2203362. PubMed ID: 36893770
[TBL] [Abstract][Full Text] [Related]
5. Cascade catalytic nanoplatform based on ions interference strategy for calcium overload therapy and ferroptosis.
Yin Y; Jiang T; Hao Y; Zhang J; Li W; Hao Y; He W; Song Y; Feng Q; Ma W
Int J Pharm; 2021 Sep; 606():120937. PubMed ID: 34310960
[TBL] [Abstract][Full Text] [Related]
6. Complementing Cancer Photodynamic Therapy with Ferroptosis through Iron Oxide Loaded Porphyrin-Grafted Lipid Nanoparticles.
Liang X; Chen M; Bhattarai P; Hameed S; Tang Y; Dai Z
ACS Nano; 2021 Dec; 15(12):20164-20180. PubMed ID: 34898184
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Targeted Cascade Nanoreactor Based on Metal-Organic Frameworks for Synergistic Ferroptosis-Starvation Anticancer Therapy.
Wan X; Song L; Pan W; Zhong H; Li N; Tang B
ACS Nano; 2020 Sep; 14(9):11017-11028. PubMed ID: 32786253
[TBL] [Abstract][Full Text] [Related]
8. Tumor-acidity and bioorthogonal chemistry-mediated construction and deconstruction of drug depots for ferroptosis under normoxia and hypoxia.
Zhou J; Wang K; Jiang M; Li J; Yuan Y
Acta Biomater; 2022 Apr; 142():253-263. PubMed ID: 35085800
[TBL] [Abstract][Full Text] [Related]
9. High-Performance Self-Cascade Pyrite Nanozymes for Apoptosis-Ferroptosis Synergistic Tumor Therapy.
Meng X; Li D; Chen L; He H; Wang Q; Hong C; He J; Gao X; Yang Y; Jiang B; Nie G; Yan X; Gao L; Fan K
ACS Nano; 2021 Mar; 15(3):5735-5751. PubMed ID: 33705663
[TBL] [Abstract][Full Text] [Related]
10. Iron-based nanoparticles for MR imaging-guided ferroptosis in combination with photodynamic therapy to enhance cancer treatment.
Chen Q; Ma X; Xie L; Chen W; Xu Z; Song E; Zhu X; Song Y
Nanoscale; 2021 Mar; 13(9):4855-4870. PubMed ID: 33624647
[TBL] [Abstract][Full Text] [Related]
11. A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy.
Hu X; Li R; Wu W; Fang K; Zhu Z; Wang Y; Zhou L; Chen M; Dong C; Shi S
J Control Release; 2022 Aug; 348():660-671. PubMed ID: 35716884
[TBL] [Abstract][Full Text] [Related]
12. Amplified Fenton-Based Oxidative Stress Utilizing Ultraviolet Upconversion Luminescence-Fueled Nanoreactors for Apoptosis-Strengthened Ferroptosis Anticancer Therapy.
Nguyen NT; Kim J; Le XT; Lee WT; Lee ES; Oh KT; Choi HG; Youn YS
ACS Nano; 2023 Jan; 17(1):382-401. PubMed ID: 36579941
[TBL] [Abstract][Full Text] [Related]
13. Photothermal nanozyme-ignited Fenton reaction-independent ferroptosis for breast cancer therapy.
Xing L; Liu XY; Zhou TJ; Wan X; Wang Y; Jiang HL
J Control Release; 2021 Nov; 339():14-26. PubMed ID: 34547257
[TBL] [Abstract][Full Text] [Related]
14. Amorphous ferric oxide-coating selenium core-shell nanoparticles: a self-preservation Pt(IV) platform for multi-modal cancer therapies through hydrogen peroxide depletion-mediated anti-angiogenesis, apoptosis and ferroptosis.
Xu Z; Li Q; Zhang C; Wang P; Xu X; Ran L; Zhang L; Tian G; Zhang G
Nanoscale; 2022 Aug; 14(32):11600-11611. PubMed ID: 35861683
[TBL] [Abstract][Full Text] [Related]
15. Precision therapy through breaking the intracellular redox balance with an MOF-based hydrogel intelligent nanobot for enhancing ferroptosis and activating immunotherapy.
Zhang D; Meng Y; Song Y; Cui P; Hu Z; Zheng X
Nanoscale; 2022 Jun; 14(23):8441-8453. PubMed ID: 35647731
[TBL] [Abstract][Full Text] [Related]
16. Self-Assembled Copper-Based Nanoparticles for Glutathione Activated and Enzymatic Cascade-Enhanced Ferroptosis and Immunotherapy in Cancer Treatment.
Song WF; Zeng JY; Ji P; Han ZY; Sun YX; Zhang XZ
Small; 2023 Aug; 19(35):e2301148. PubMed ID: 37118853
[TBL] [Abstract][Full Text] [Related]
17. Renal Clearable Ultrasmall Single-Crystal Fe Nanoparticles for Highly Selective and Effective Ferroptosis Therapy and Immunotherapy.
Liang H; Wu X; Zhao G; Feng K; Ni K; Sun X
J Am Chem Soc; 2021 Sep; 143(38):15812-15823. PubMed ID: 34473493
[TBL] [Abstract][Full Text] [Related]
18. Polypeptide-Based Theranostics with Tumor-Microenvironment-Activatable Cascade Reaction for Chemo-ferroptosis Combination Therapy.
Gao Z; He T; Zhang P; Li X; Zhang Y; Lin J; Hao J; Huang P; Cui J
ACS Appl Mater Interfaces; 2020 May; 12(18):20271-20280. PubMed ID: 32283924
[TBL] [Abstract][Full Text] [Related]
19. FePt@MnO-Based Nanotheranostic Platform with Acidity-Triggered Dual-Ions Release for Enhanced MR Imaging-Guided Ferroptosis Chemodynamic Therapy.
Yang B; Liu Q; Yao X; Zhang D; Dai Z; Cui P; Zhang G; Zheng X; Yu D
ACS Appl Mater Interfaces; 2019 Oct; 11(42):38395-38404. PubMed ID: 31554396
[TBL] [Abstract][Full Text] [Related]
20. Dual-Responsive multifunctional "core-shell" magnetic nanoparticles promoting Fenton reaction for tumor ferroptosis therapy.
Chi H; Zhu G; Yin Y; Diao H; Liu Z; Sun S; Guo Z; Xu W; Xu J; Cui C; Xing XJ; Ma K
Int J Pharm; 2022 Jun; 622():121898. PubMed ID: 35688287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
